ADC Therapeutics Cash from Financing (TTM) Analysis

ADC Therapeutics SA (ADCT)

4.43 -0.28 (-5.94%) USD | NYSE | May 02, 11:11

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	73.88M
September 30, 2023	69.48M
June 30, 2023	74.16M
March 31, 2023	-0.835M
December 31, 2022	-0.897M
September 30, 2022	0.637M
June 30, 2022	217.58M

Date	Value
March 31, 2022	267.43M
December 31, 2021	267.39M
September 30, 2021	265.74M
June 30, 2021	237.72M
March 31, 2021	494.95M
December 31, 2020	494.97M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.897M

Minimum

Dec 2022

494.97M

Maximum

Dec 2020

189.40M

Average

217.58M

Median

Jun 2022

Cash from Financing (TTM) Benchmarks